Risk models of cancer-related cognitive complaints among early breast cancer survivors in the CANTO cohort

Approximately 1 in 3 BC survivors in this cohort reported CRCC at diagnosis, with this rate being stable until year-4 after diagnosis. Pretreatment symptom burden and chemotherapy were validated as risk factors for long-term CRCC. No associations between inflammatory markers and self-reported CRCC emerged from this study.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2025-08-31
DOI
https://doi.org/10.1093/jnci/djaf256
Primary Topic
Cancer-related cognitive impairment studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk models of cancer-related cognitive complaints among early breast cancer survivors in the CANTO cohort

Martina Pagliuca, Sandrine Boyault, Florence Joly, Anne‐Laure Martin et al.
1 links
JNCI Journal of the National Cancer Institute
Cancer-related cognitive impairment studies
article

Risk models of cancer-related cognitive complaints among early breast cancer survivors in the CANTO cohort

Martina Pagliuca, Sandrine Boyault, Florence Joly, Anne‐Laure Martin, Bianca Cheaib, Olivier Trédan, Caroline Pradon, Daniele Presti, Antonio Di Meglio, Florence Lerebours, Julie Havas, François Cherifi, Anne Kieffer, Marie Lange, Marion Fournier, Mario Campone, Aurélie Bertaut, Christelle Jouannaud, Inês Vaz-Luís, Thierry Petit, Catherine Gaudin
article en

Abstract

Approximately 1 in 3 BC survivors in this cohort reported CRCC at diagnosis, with this rate being stable until year-4 after diagnosis. Pretreatment symptom burden and chemotherapy were validated as risk factors for long-term CRCC. No associations between inflammatory markers and self-reported CRCC emerged from this study.

JNCI Journal of the National Cancer InstituteVol. 117(12)
Université Claude Bernard Lyon 1 (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), Institut de Cancérologie Strasbourg (FR), Centre Georges François Leclerc (FR), Institut de Cancérologie de Lorraine (FR), Centre François Baclesse (LU), Centre Léon Bérard (FR), Normandie Université (FR), Institut de Cancérologie de l'Ouest (FR), Centre François Baclesse (FR), Centre de Recherche en Cancérologie de Lyon (FR), Institut Bergonié (FR), UniCancer Group (FR), Scuola Superiore Meridionale (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Institut Jean Godinot (FR), European Institute of Oncology (IT), Université de Strasbourg (FR), Institut Curie (FR), Université de Caen Normandie (FR)
Openalex Percentile: Top 66%
Cancer-related cognitive impairment studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.